Ali McBride

3.9k total citations
234 papers, 2.7k citations indexed

About

Ali McBride is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Ali McBride has authored 234 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Oncology, 64 papers in Hematology and 51 papers in Genetics. Recurrent topics in Ali McBride's work include Neutropenia and Cancer Infections (46 papers), Economic and Financial Impacts of Cancer (29 papers) and Chronic Lymphocytic Leukemia Research (28 papers). Ali McBride is often cited by papers focused on Neutropenia and Cancer Infections (46 papers), Economic and Financial Impacts of Cancer (29 papers) and Chronic Lymphocytic Leukemia Research (28 papers). Ali McBride collaborates with scholars based in United States, United Kingdom and Saudi Arabia. Ali McBride's co-authors include Ivo Abraham, Faiz Anwer, Marion Slack, Brian L. Erstad, Peter Westervelt, Karen MacDonald, Abdulaali R. Almutairi, Hani M. Babiker, Jennifer Martin and Irbaz Bin Riaz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Ali McBride

209 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali McBride United States 28 1.4k 534 516 490 480 234 2.7k
Gerardo Colón‐Otero United States 30 2.0k 1.5× 331 0.6× 608 1.2× 595 1.2× 407 0.8× 99 3.5k
Bhawna Sirohi India 33 1.7k 1.2× 325 0.6× 792 1.5× 817 1.7× 1.2k 2.5× 171 3.8k
Jean‐Paul Guastalla France 31 2.2k 1.6× 586 1.1× 495 1.0× 621 1.3× 177 0.4× 109 3.7k
Peter Barrett‐Lee United Kingdom 35 2.6k 1.9× 163 0.3× 671 1.3× 885 1.8× 807 1.7× 121 5.0k
Dianne Pulte United States 31 1.4k 1.0× 255 0.5× 402 0.8× 1.0k 2.1× 1.4k 2.8× 87 3.5k
P. Pronzato Italy 32 2.5k 1.8× 242 0.5× 884 1.7× 731 1.5× 254 0.5× 231 4.4k
N. Tubiana-Mathieu France 30 2.0k 1.5× 163 0.3× 644 1.2× 436 0.9× 268 0.6× 166 3.2k
Ralph M. Meyer Canada 36 1.7k 1.2× 335 0.6× 827 1.6× 449 0.9× 1.5k 3.0× 139 4.7k
Linda D. Bosserman United States 24 1.8k 1.3× 157 0.3× 513 1.0× 295 0.6× 267 0.6× 89 3.3k
Glenn Mills United States 26 1.9k 1.4× 172 0.3× 930 1.8× 673 1.4× 428 0.9× 119 3.4k

Countries citing papers authored by Ali McBride

Since Specialization
Citations

This map shows the geographic impact of Ali McBride's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali McBride with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali McBride more than expected).

Fields of papers citing papers by Ali McBride

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali McBride. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali McBride. The network helps show where Ali McBride may publish in the future.

Co-authorship network of co-authors of Ali McBride

This figure shows the co-authorship network connecting the top 25 collaborators of Ali McBride. A scholar is included among the top collaborators of Ali McBride based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali McBride. Ali McBride is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Markman, B., Martin Gutierrez, James A. Henry, et al.. (2025). 916O Preliminary phase I results of INCB161734, a novel oral KRAS G12D inhibitor, in patients with advanced or metastatic solid tumors. Annals of Oncology. 36. S559–S560.
3.
Andritsos, Leslie A., Ali McBride, Derek Tang, et al.. (2024). Real-world impact of luspatercept on red blood cell transfusions among patients with myelodysplastic syndromes: A United States healthcare claims database study. Leukemia Research. 148. 107624–107624. 2 indexed citations
4.
Garcia‐Manero, Guillermo, Rayna K. Matsuno, Ali McBride, et al.. (2024). Clinical Outcomes and Healthcare Resource Utilization for Patients With Lower-Risk Myelodysplastic Syndromes Treated With Erythropoiesis-Stimulating Agents. Clinical Lymphoma Myeloma & Leukemia. 24(9). e283–e292.
5.
6.
Alsuhebany, Nada, et al.. (2023). Zanubrutinib in Mantle Cell Lymphoma Management: A Comprehensive Review. PubMed. Volume 13. 67–76. 4 indexed citations
7.
Klink, Andrew J., Ajeet Gajra, Russell L. Knoth, et al.. (2022). Real-world clinical outcomes with enasidenib in relapsed or refractory acute myeloid leukemia. Leukemia Research. 122. 106946–106946. 1 indexed citations
8.
Harvey, Michael J., et al.. (2021). Budget Impact Analysis of Comprehensive Genomic Profiling in Patients With Advanced Non–Small-Cell Lung Cancer. JCO Precision Oncology. 5(5). 1611–1624. 13 indexed citations
9.
10.
Oh, Mok, Joanne Jeter, Jennifer Martin, et al.. (2019). The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta‐analysis. The Prostate. 79(8). 880–895. 90 indexed citations
11.
Sardar, Muhammad, Saad Ullah Malik, Ali Younas Khan, et al.. (2019). Efficacy of Ibrutinib-Based Regimen in Chronic Lymphocytic Leukemia: A Systematic Review. Journal of Hematology. 8(1). 1–10. 4 indexed citations
12.
Recio‐Boiles, Alejandro, Hani M. Babiker, Aaron J. Scott, et al.. (2019). Evaluation of the safety and effectiveness of direct oral anticoagulants and low molecular weight heparin in gastrointestinal cancer-associated venous thromboembolism. World Journal of Gastrointestinal Oncology. 11(10). 866–876. 13 indexed citations
13.
14.
Zahid, Umar, Ahmad Iftikhar, Seongseok Yun, et al.. (2017). Role of High Dose Chemotherapy and Autologous Stem Cell Transplant in Relapsed Ewing's Sarcoma — a Systematic Review. Blood. 130. 2014–2014. 1 indexed citations
15.
Yun, Seongseok, et al.. (2017). Waldenström Macroglobulinemia: Review of Pathogenesis and Management. Clinical Lymphoma Myeloma & Leukemia. 17(5). 252–262. 31 indexed citations
16.
Bootman, J. Lyle, et al.. (2016). Economic Evaluations of First-Line Chemotherapy Regimens for Pancreatic Cancer: A Critical Review. PharmacoEconomics. 35(1). 83–95. 10 indexed citations
17.
McBride, Ali, et al.. (2015). Economic evaluation for the UK of nab-paclitaxel plus gemcitabine in the treatment of metastatic pancreas cancer. British Journal of Cancer. 112(8). 1301–1305. 17 indexed citations
18.
19.
Haverkos, Bradley M., Ali McBride, Lynn O’Donnell, et al.. (2014). An effective mobilization strategy for lymphoma patients after failed upfront mobilization with plerixafor. Bone Marrow Transplantation. 49(8). 1052–1055. 6 indexed citations
20.
Yang, Runying, Ali McBride, Yue-xian Hou, Aaron D. Goldberg, & Xiu-Bao Chang. (2005). Nucleotide dissociation from NBD1 promotes solute transport by MRP1. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1668(2). 248–261. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerardo Colón‐Otero Breakdown of academic impact, for papers by Bhawna Sirohi Breakdown of academic impact, for papers by Jean‐Paul Guastalla Breakdown of academic impact, for papers by Peter Barrett‐Lee Breakdown of academic impact, for papers by Dianne Pulte Breakdown of academic impact, for papers by P. Pronzato Breakdown of academic impact, for papers by N. Tubiana-Mathieu Breakdown of academic impact, for papers by Ralph M. Meyer Breakdown of academic impact, for papers by Linda D. Bosserman Breakdown of academic impact, for papers by Glenn Mills
Rankless by CCL
2026